Ironare are committed to the development of successful human medicines. Drugmaking is not a statistical event, nor simply a high-throughput industrialized pursuit. Our team is forging a process for creating and developing novel drug candidates that integrates the most successful drugmaking practices of the past and the best of today's cutting-edge technologies. Our efficient discovery and development processes, focused on important human needs, are generating a robust pipeline.

Tallahassee Memorial HealthCare is a community health system serving the residents of Florida's state capital and surrounding communities. The system is anchored by Tallahassee Memorial Hospital, a not-for-profit facility with about 770 beds. Founded in 1948, the hospital provides general medical and surgical care, as well as specialty care in a number of areas, including oncology, rehabilitation, women's and children's health, obesity, and diabetes. Tallahassee Memorial HealthCare also offers a family practice residency program and provides primary medical care through a handful of regional clinics. It has a 60-bed psychiatric hospital, and offers adult day care and home health care services.

Children's Memorial Hospital has the Windy City covered. Founded in 1882, the hospital provides a full range of pediatric services, both acute and specialty care. Children's Memorial provides its services through its main hospital campus with about 300 beds and outpatient center in Chicago's Lincoln Park neighborhood, as well as through more than a dozen suburban outpatient centers and outreach partner locations in the greater Chicago metropolitan area. The hospital also operates Children's Memorial Research Center, a national leader in pediatric research, and it is the pediatric teaching facility of Northwestern University's Feinberg School of Medicine.

Palomar Medical Technologies' laser light show is more functional than flashy. Palomar makes laser and pulsed-light systems, along with related disposable products, for use in aesthetic procedures. The company's products include the EsteLux, StarLux, and MediLux systems. The systems, which are paired with a variety of handpieces, are used for skin resurfacing and acne treatments, hair removal, and treatment of leg veins, among other procedures. Additionally, Palomar's Q-YAG 5 laser removes tattoos and pigmented lesions. The firm markets its products through a direct sales force and distributors around the world.

Refocus Group is a medical device company that develops surgical treatments for human vision disorders. Therapeutic targets include presbyopia (commonly known as farsightedness), elevated blood pressure in the eye, and a certain form of glaucoma. Its most advanced device is the Scleral Spacing Procedure, which includes an incision handpiece, implants, and related surgical equipment, that could treat the previously mentioned vision disorders. Medcare Investment owns more than half of the firm.

World Heart develops VADs (ventricular assist devices) that can be implanted within the chest cavity next to the natural heart. Through the transcutaneous energy and information transfer (TEIT) system, electric power is used to monitor and control the heart. The devices are used as a bridging device for patients awaiting a transplant and for long-term support. World Heart's main product is the Novacor LVAS. The company has facilities in the US, the Netherlands, and Canada. World Heart is developing next-generation VAD products.

OSF Healthcare helps patients who are feeling oh-so-frail in Illinois and Michigan. OSF Healthcare system includes seven acute care hospitals and one long-term care facility that combined are home to about 1,300 beds and offer a full spectrum of inpatient and outpatient medical and surgical services. The system's primary care physician network consists of about 500 physicians at more than 50 locations throughout its service area. Subsidiary OSF Home Care provides hospice, home visit, and equipment services, and OSF Saint Francis provides ambulance, pharmacy, and health care management services. The not-for-profit system is a subsidiary of the Sisters of The Third Order of St. Francis.

China Medical Technologies, Inc. (the "Company") is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders. China Medical Technologies was listed on the Nasdaq Global Select Market on August 10, 2005 and trades under the ticker "CMED". ECLIA is operated through our wholly-owned subsidiary Beijing Yuande Bio-Medical Engineering Co., Ltd. ("Yuande") in China. Yuande was established in 1999 and its headquarters and manufacturing facilities are located in the Beijing Economic-Technological Development Area. The Company was awarded ISO 9001 certification and ISO 13485:2003 certification in 2006.Our first ECLIA analyzers and reagents were launched in 2004. In light of the Company's extensive research in chemiluminescence technology, we believe we are one of the first China-based companies to successfully develop the products and, more importantly, the first to offer an integrated platform including self-developed analyzers and reagents. We manufacture both the equipment and reagents that detect and monitor various diseases and disorders by analyzing blood through laboratory evaluation. FISH and SPR are operated through our other wholly-owned subsidiary, Beijing GP Medical Technologies, Ltd., which was established in 2006. We acquired our FISH business in March 2007 and launched our FISH-related products in the same year. We believe the FISH products will complement our existing ECLIA diagnostic products by providing proprietary tests for the diagnosis of prenatal and postnatal disorders as well as various cancers that arise from genetic mutations.

Safety Syringes wants to ensure that when you're getting needled, it's with deliberate intention. The company manufactures devices designed to prevent accidental needle pricks. Safety Syringe's products include UltraSafe Needle Guards, which attach to prefilled glass syringes, and UltraSafe Passive Needle Guards, in which a safety guard locks into place upon completion of shot delivery. The company develops products used for medical and dental drug delivery, vaccines, blood collection, and intravenous catheters. Customers for pre-filled syringes include Amgen, Merck, Roche, and Pfizer. The company was founded in 1990 and primarily operates in North America, Europe, and Asia.

Progressive Medical hopes its pressure therapy will make progress in getting rid of bed sores. The company sells a variety of therapeutic air and foam mattresses and related medical products to patients with wound care needs, pulmonary complications, and immobility (i.e. paraplegics and quadriplegics). Its mattresses help to prevent and also heal patients' bedsores. The company's other products include negative pressure (vacuum) wound therapy systems and durable medical equipment (wheelchairs, walkers, and commodes), as well as products for bariatric patients. Progressive Medical also provides consulting and condition assessment services.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.